Hält derzeit eine Position bei Fate Therapeutics Inc
Position | Company | Period |
---|---|---|
Vice President - Clinical Devel | Fate Therapeutics Inc | 18. April 2019 - |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-01-11 | 2023-01-10 |
Fate Therapeutics Inc
(FATE)
|
V Verkauf |
7.825
-5.2%
5,2441.003 USD |
7.825 -5.2% | 5,24 | 41.003 USD | |
2022-04-21 | 2022-04-19 |
Fate Therapeutics Inc
(FATE)
|
V Verkauf |
4.062
-2.6%
35,37143.673 USD |
4.062 -2.6% | 35,37 | 143.673 USD | |
2022-01-13 | 2022-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Verkauf |
418
-0.3%
49,1020.524 USD |
418 -0.3% | 49,10 | 20.524 USD | |
2022-01-13 | 2022-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Verkauf |
3.547
-2.8%
48,44171.817 USD |
3.547 -2.8% | 48,44 | 171.817 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
GV Geplanter Verkauf |
5
-0.0%
55,54278 USD |
5 -0.0% | 55,54 | 278 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
GV Geplanter Verkauf |
600
-0.5%
54,5832.748 USD |
600 -0.5% | 54,58 | 32.748 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
GV Geplanter Verkauf |
1.031
-0.8%
53,6655.323 USD |
1.031 -0.8% | 53,66 | 55.323 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
GV Geplanter Verkauf |
1.822
-1.4%
52,3795.418 USD |
1.822 -1.4% | 52,37 | 95.418 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
GV Geplanter Verkauf |
1.045
-0.8%
51,0853.379 USD |
1.045 -0.8% | 51,08 | 53.379 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
GV Geplanter Verkauf |
900
-0.7%
50,4245.378 USD |
900 -0.7% | 50,42 | 45.378 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
GV Geplanter Verkauf |
2.097
-1.6%
49,32103.424 USD |
2.097 -1.6% | 49,32 | 103.424 USD | |
2021-04-20 | 2021-04-16 |
Fate Therapeutics Inc
(FATE)
|
V Verkauf |
1.500
-2.3%
84,41126.615 USD |
1.500 -2.3% | 84,41 | 126.615 USD | |
2021-04-20 | 2021-04-16 |
Fate Therapeutics Inc
(FATE)
|
V Verkauf |
900
-1.3%
82,9174.619 USD |
900 -1.3% | 82,91 | 74.619 USD | |
2021-04-20 | 2021-04-16 |
Fate Therapeutics Inc
(FATE)
|
V Verkauf |
875
-1.3%
81,8071.575 USD |
875 -1.3% | 81,80 | 71.575 USD |